In many trials of cardiovascular medications, particularly in secondary prevention, all-cause mortality does not significantly change despite reductions in recurrent coronary events.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.